203 related articles for article (PubMed ID: 19717376)
1. Mantle cell lymphoma: biological insights and treatment advances.
Leonard JP; Williams ME; Goy A; Grant S; Pfreundschuh M; Rosen ST; Sweetenham JW
Clin Lymphoma Myeloma; 2009 Aug; 9(4):267-77. PubMed ID: 19717376
[TBL] [Abstract][Full Text] [Related]
2. Mantle cell lymphoma in relapse: the role of emerging new drugs.
Diefenbach CS; O'Connor OA
Curr Opin Oncol; 2010 Sep; 22(5):419-23. PubMed ID: 20679769
[TBL] [Abstract][Full Text] [Related]
3. Update on the molecular biology of mantle cell lymphoma.
Bertoni F; Rinaldi A; Zucca E; Cavalli F
Hematol Oncol; 2006 Mar; 24(1):22-7. PubMed ID: 16402392
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
[TBL] [Abstract][Full Text] [Related]
6. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
[TBL] [Abstract][Full Text] [Related]
7. Management of mantle cell lymphoma: key challenges and next steps.
Williams ME; Dreyling M; Winter J; Muneer S; Leonard JP
Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):336-46. PubMed ID: 21030346
[TBL] [Abstract][Full Text] [Related]
8. Current treatment approaches for mantle-cell lymphoma.
Witzig TE
J Clin Oncol; 2005 Sep; 23(26):6409-14. PubMed ID: 16155027
[TBL] [Abstract][Full Text] [Related]
9. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.
Jares P; Colomer D; Campo E
Nat Rev Cancer; 2007 Oct; 7(10):750-62. PubMed ID: 17891190
[TBL] [Abstract][Full Text] [Related]
10. Treatment of mantle cell lymphoma: current approach and future directions.
Brody J; Advani R
Crit Rev Oncol Hematol; 2006 Jun; 58(3):257-65. PubMed ID: 16751087
[TBL] [Abstract][Full Text] [Related]
11. Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved?
Dreyling M; Hiddemann W
Curr Opin Oncol; 2008 Sep; 20(5):487-94. PubMed ID: 19106649
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of mantle cell lymphoma: from profiling studies to new therapeutic strategies.
Obrador-Hevia A; Fernández de Mattos S; Villalonga P; Rodríguez J
Blood Rev; 2009 Sep; 23(5):205-16. PubMed ID: 19362399
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-based therapy for mantle cell lymphoma.
Munger CM; Vose JM; Joshi SS
Int J Oncol; 2006 Jun; 28(6):1337-43. PubMed ID: 16685434
[TBL] [Abstract][Full Text] [Related]
14. Mantle cell lymphoma: advances in biology and therapy.
Smith MR
Curr Opin Hematol; 2008 Jul; 15(4):415-21. PubMed ID: 18536582
[TBL] [Abstract][Full Text] [Related]
15. A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.
Evens AM; Winter JN; Hou N; Nelson BP; Rademaker A; Patton D; Singhal S; Frankfurt O; Tallman MS; Rosen ST; Mehta J; Gordon LI
Br J Haematol; 2008 Feb; 140(4):385-93. PubMed ID: 18162124
[TBL] [Abstract][Full Text] [Related]
16. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
17. [Current strategies in the treatment of advanced stage mantle cell lymphoma].
Lenz G; Dreyling M; Unterhalt M; Hiddemann W
Dtsch Med Wochenschr; 2004 Nov; 129(45):2429-33. PubMed ID: 15529247
[TBL] [Abstract][Full Text] [Related]
18. Mantle cell lymphoma: established therapeutic options and future directions.
Lenz G; Dreyling M; Hiddemann W
Ann Hematol; 2004 Feb; 83(2):71-7. PubMed ID: 14669040
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiling of mantle cell lymphoma.
Menanteau MR; Martinez-Climent JA
Methods Mol Biol; 2013; 973():147-63. PubMed ID: 23412788
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma.
Thieblemont C; Antal D; Lacotte-Thierry L; Delwail V; Espinouse D; Michallet AS; Traulle C; Bouafia-Sauvy F; Giraud C; Salles G; Guilhot F; Coiffier B
Cancer; 2005 Oct; 104(7):1434-41. PubMed ID: 16104036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
